Chemical IPO performance stayed uneven. Stallion India Fluorochemicals led the pack, while Arunaya Organics and Neochem Bio Solutions lagged due to cost pressures and weak demand visibility.
Chemical IPOs produced mixed outcomes. Specialty chemical names tied to exports and niche applications gained, while others slipped amid margin pressure and volatile input costs.
Investors quickly differentiated between scalable chemistry and commoditised production.
Chemicals (7 IPOs, Avg YTD: +16.0%)
| Rank | Company Name | Symbol | Issue Price (₹) | LTP (₹) | YTD Return (%) |
|---|---|---|---|---|---|
| 1 | Stallion India Fluorochemicals | STALLION | 90.00 | 244.66 | 171.84 |
| 2 | Neochem Bio Solutions | NEOCHEM | 98.00 | 85.60 | -12.65 |
| 3 | Speb Adhesives Limited | SPEB | 56.00 | 54.00 | -3.57 |
| 4 | Arunaya Organics Limited | ARUNAYA | 112.00 | 39.20 | -65.00 |
| 5 | Barflex Polyfilms Limited | BARFLEX | 60.00 | 75.50 | 25.83 |
| 6 | Clear Secured Services | CSSL | 132.00 | 120.50 | -8.71 |
| 7 | Fujiyama Power Systems | UTLSOLAR | 228.00 | 216.02 | -5.25 |
Across India’s 217 IPOs in 2025, wealth creation was highly selective. Healthcare and tech produced the biggest winners, while Industrials and Financials demanded patience. For investors, the year reinforced one lesson: sector tailwinds help—but fundamentals decide outcomes.
